BOOTHBAY FUND MANAGEMENT, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$109,000
-86.0%
96,883
-62.8%
0.00%
-83.3%
Q1 2022$778,000
+489.4%
260,146
+423.1%
0.02%
+500.0%
Q4 2021$132,000
-45.2%
49,735
-25.2%
0.00%
-57.1%
Q3 2021$241,000
-18.9%
66,522
-2.8%
0.01%
-30.0%
Q2 2021$297,000
+139.5%
68,456
+88.5%
0.01%
+100.0%
Q1 2021$124,000
-58.4%
36,319
-57.3%
0.01%
-54.5%
Q4 2020$298,000
-40.5%
85,049
-59.3%
0.01%
-63.3%
Q3 2020$501,000
+17.6%
208,821
-10.3%
0.03%
+3.4%
Q2 2020$426,000
+25.7%
232,850
+7.3%
0.03%
+3.6%
Q1 2020$339,000
+149.3%
217,050
+241.2%
0.03%
+133.3%
Q4 2019$136,000
+142.9%
63,609
+319.5%
0.01%0.0%
Q3 2016$56,000
-18.8%
15,163
-50.8%
0.01%
-55.6%
Q2 2016$69,000
+4.5%
30,830
-2.5%
0.03%
+8.0%
Q1 2016$66,000
-10.8%
31,610
+28.7%
0.02%
-24.2%
Q4 2015$74,000
+76.2%
24,568
+43.9%
0.03%
+65.0%
Q3 2015$42,000
+2.4%
17,068
+50.2%
0.02%
-25.9%
Q1 2015$41,00011,3600.03%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders